Experimental vaccination with nanoparticles containing Escherichia coli virulence factors

Melibea Berzosa , Yadira Pastor, Juan M Irache, Carlos Gamazo

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

2 Citations (Scopus)

Abstract

Pathogenic Escherichia coli strains are leading causes of morbidity and mortality worldwide, particularly among children in low- and middle-income countries. To overcome this challenge, the development of vaccines is extremely necessary. However, there exists a large variety of different pathotypes which differ in relation to their virulence factors and mechanism of colonization. Consequently, a common immunoprotective mechanism is unlikely to exist, making harder the search for E. coli vaccines. In the first part, this chapter reviews the main E. coli pathotypes virulence factors, in light of potential targets for vaccination, with special focus on Enterotoxigenic and Enterohemorrhagic E. coli strains. After that, we will describe studies performed to improve vaccine efficacy by using new adjuvants based on nanotechnology which might contribute to prevent this very serious global matter.
Original languageEnglish
Title of host publicationApplications of nanobiotechnology for neglected tropical diseases
Editors Fabio Rocha Formiga, Inamuddin, Patrícia Severino
PublisherElsevier
Chapter1
Pages3-27
ISBN (Electronic)9780128211014
ISBN (Print)9780128211007
DOIs
Publication statusPublished - 20 Feb 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Experimental vaccination with nanoparticles containing Escherichia coli virulence factors'. Together they form a unique fingerprint.

Cite this